Silicon Valley
fromSFGATE
3 weeks agoBay Area biotech company, down from $1B to $78M, lays off a third of workers
Sutro Biopharma is laying off roughly a third of remaining staff to extend its cash runway into mid-2027 while advancing antibody-drug conjugate clinical plans.